Leukemia: A Review of Data from the ASCO and EHA 2023 Meetings

home / the-talk / leukemia-a-review-of-data-from-the-asco-and-eha-2023-meetings

A panel of experts discusses key datasets in leukemia that were presented recently at the American Society of Clinical Oncology [ASCO] 2023 Annual Meeting and the European Hematology Association [EHA] 2023 Congress.

Chronic Myeloid Leukemia: Trial Data From the ASCO and EHA 2023 Annual Meetings

EP. 1: Chronic Myeloid Leukemia: Trial Data From the ASCO and EHA 2023 Annual Meetings

August 31st 2023

Expert perspectives on key data in chronic myeloid leukemia from the ASCO 2023 and EHA 2023 Annual Meetings.

Acute Lymphoblastic Leukemia: Trial Data From the ASCO and EHA 2023 Annual Meetings

EP. 2: Acute Lymphoblastic Leukemia: Trial Data From the ASCO and EHA 2023 Annual Meetings

August 31st 2023

Shared insight from key opinion leaders on clinical trial data in acute lymphoblastic leukemia from the ASCO 2023 and EHA 2023 Annual Meetings.

Acute Myeloid Leukemia: Trial Data From the ASCO and EHA 2023 Annual Meetings

EP. 3: Acute Myeloid Leukemia: Trial Data From the ASCO and EHA 2023 Annual Meetings

August 31st 2023

Following the ASCO 2023 and EHA 2023 Annual Meetings, experts discuss important updates in acute myeloid leukemia.